Early single clinical experience with the new Figulla ASD Occluder for transcatheter closure of atrial septal defect in adults

Basit Öğe Kaydı
dc.authoridAkaycan, Jülide/0000-0002-9174-6777
dc.authoridTaşolar, Hakan/0000-0002-1249-7240
dc.authoridPekdemir, Hasan/0000-0002-4913-5120
dc.authoridCansel, Mehmet/0000-0003-4740-4371;
dc.authorwosidAkaycan, Jülide/ABI-2397-2020
dc.authorwosidTaşolar, Hakan/ABG-4466-2020
dc.authorwosidPekdemir, Hasan/ABI-6096-2020
dc.authorwosidCansel, Mehmet/ABI-6324-2020
dc.authorwosidErmis, Necip/HJP-7061-2023
dc.authorwosidErmis, Necip/A-5184-2018
dc.authorwosidmiaoyue, chen/A-6575-2012
dc.contributor.authorCansel, Mehmet
dc.contributor.authorPekdemir, Hasan
dc.contributor.authorYagmur, Julide
dc.contributor.authorTasolar, Hakan
dc.contributor.authorErmis, Necip
dc.contributor.authorKurtoglu, Ertugrul
dc.contributor.authorAcikgoz, Nusret
dc.date.accessioned2024-08-04T20:32:49Z
dc.date.available2024-08-04T20:32:49Z
dc.date.issued2011
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground. Recently, the Occlutech Figulla ASD Occluder (FSO) has been introduced for transcatheter closure of atrial septal defects. This device can be used for transcatheter closure of small as well as large atrial septal defects. Aims. To evaluate the feasibility and short-term results of transcatheter closure of secundum type atrial septal defects using the FSO device in adult patients. Methods. Seventy-four consecutive adult patients were referred for transcatheter closure of secundum large atrial septal defects (stretched diameter > 20 mm and/or invasive pulmonary/systemic flow [Qp/Qs] ratio > 1.5) using the FSO device. Results. The FSO device was successfully implanted in 68 patients (mean +/- SD [range] age: 31.8 +/- 12.3 [17-64] years; weight: 71.5 +/- 18.4 [49-98] kg). All patients had right atrial and ventricular volume overload with a mean Qp/Qs ratio of 2.5 +/- 0.6 (range 1.5-3.8). Mean atrial septal defect diameter was 22.3 +/- 4.8 (range 12-33) mm and the size of the implanted FSO was 24.1 +/- 4.9 (range 12-36) mm. Two patients had trivial (jet width <1 mm in diameter) residual shunts and one patient had a small (1-2 mm) residual shunt. There were no moderate or severe residual shunts. No device embolization or other serious complication occurred during either the procedure or the follow-up. Conclusion. The present study found that transcatheter closure of isolated secundum atrial septal defects using the novel design of the FSO device was safe, effective, and had an excellent outcome during the 6 month follow-up period. (C) 2011 Elsevier Masson SAS. All rights reserved.en_US
dc.identifier.doi10.1016/j.acvd.2010.12.006
dc.identifier.endpage160en_US
dc.identifier.issn1875-2136
dc.identifier.issn1875-2128
dc.identifier.issue3en_US
dc.identifier.pmid21497304en_US
dc.identifier.scopus2-s2.0-79954507734en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage155en_US
dc.identifier.urihttps://doi.org/10.1016/j.acvd.2010.12.006
dc.identifier.urihttps://hdl.handle.net/11616/95300
dc.identifier.volume104en_US
dc.identifier.wosWOS:000290605400003en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Massonen_US
dc.relation.ispartofArchives of Cardiovascular Diseasesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAtrial septal defectsen_US
dc.subjectSeptal occluder deviceen_US
dc.titleEarly single clinical experience with the new Figulla ASD Occluder for transcatheter closure of atrial septal defect in adultsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu